LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.17408
Abstract: Idiopathic short stature (ISS) is the most common paediatric endocrine disease. However, the underlying pathology of ISS remains unclear. Currently, there are no effective diagnostic markers or therapeutic strategies available for ISS. In this study,… read more here.
Keywords: new diagnostic; lcn2 new; stature; short stature ... See more keywords